Form 4 for MEDP Medpace Holdings, Inc.
Accepted 2023-09-20 00:00:00 ET · period of report 2023-09-18 · accession 0000892251-23-000145 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2023-09-20 | 2023-09-18+ | MEDP | Medpace Investors, LLC | 10% | S - Sale | $263.89 | -190.8K | 6.18M | -3% | -$50.34M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-19 | S | D | 137,379 | $259.66 | 6,042,255 | D | — | — | (F3) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $254.74 to $271.42. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |
| 2 | Common | Common Stock | 2023-09-18 | S | D | 53,385 | $274.76 | 6,179,634 | D | — | — | (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $271.505 to $278.665. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |